Articles by Alana Klein - Pharmaceutical Executive


Articles by Alana Klein

Marketing to Professionals: Penetrating P&T

Committee members reveal what it takes to get a drug on their radar screen.
Aug 1, 2005

As a result of the rapid innovations in drug technology, and the increasing complexities surrounding drugs' safety, cost, and efficacy, the demand for extensive formulary reviews is growing. To keep pace, Pharmacy & Therapeutics (P&T) committees have been ardently reviewing medications to determine which ones deserve inclusion and preferred placements in health plans and formularies. While there are many factors that influence the committees' decisions, with some carrying more weight than others, pharmaceutical execs complain that there is no accurate way to predict which drugs will make the cut.


Click here